Hoth Therapeutics, Inc. financial data

Symbol
HOTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
590 Madison Avenue, 21 St Floor, New York, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.28K % +75.3%
Debt-to-equity 8.57 % -52.7%
Return On Equity -89.7 % +12.7%
Return On Assets -82.6 % +5.08%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.9M shares +58.8%
Common Stock, Shares, Outstanding 6.9M shares +58.8%
Entity Public Float 9.8M USD -25.2%
Common Stock, Value, Issued 690 USD +58.6%
Weighted Average Number of Shares Outstanding, Basic 6.9M shares +98.2%
Weighted Average Number of Shares Outstanding, Diluted 6.9M shares +98.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.24B USD
Research and Development Expense 2.84M USD -31.1%
General and Administrative Expense 4.69M USD +10.4%
Costs and Expenses 29K USD
Operating Income (Loss) -7.53M USD +20%
Nonoperating Income (Expense) 22.5K USD -96.9%
Net Income (Loss) Attributable to Parent -7.51M USD +22%
Earnings Per Share, Basic -1.26 USD/shares +73%
Earnings Per Share, Diluted -1.26 USD/shares +73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8M USD -32.4%
Marketable Securities, Current 24.6K USD
Assets, Current 8.24M USD -31.7%
Operating Lease, Right-of-Use Asset 33.8K USD
Other Assets, Noncurrent 85K USD
Assets 8.31M USD -31.3%
Accounts Payable, Current 505K USD -28.6%
Accrued Liabilities, Current 274K USD -68.5%
Liabilities, Current 810K USD -48.7%
Operating Lease, Liability, Noncurrent 2.71K USD
Liabilities 813K USD -48.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 25.6K USD +12.6%
Retained Earnings (Accumulated Deficit) -58.7M USD -14.7%
Stockholders' Equity Attributable to Parent 7.49M USD -28.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.9M USD +50.5%
Liabilities and Equity 8.31M USD -31.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.72M USD +24.7%
Net Cash Provided by (Used in) Financing Activities 8.91M USD
Net Cash Provided by (Used in) Investing Activities -25K USD -103%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 6.9M shares +58.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.62M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.02M USD -32.2%
Deferred Tax Assets, Valuation Allowance 15.3M USD +19.5%
Deferred Tax Assets, Gross 15.3M USD +19.5%
Operating Lease, Liability 33.8K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.5M USD +22.3%
Lessee, Operating Lease, Liability, to be Paid 35.5K USD
Operating Lease, Liability, Current 31.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.73K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 32.8K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.71K USD
Deferred Tax Assets, Operating Loss Carryforwards 11.9M USD +14.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 66.2M USD +7.28%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 283K USD +48.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%